SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-23-006208
Filing Date
2023-05-11
Accepted
2023-05-11 16:07:10
Documents
44
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q drma_10q.htm   iXBRL 10-Q 504043
2 CERTIFICATION drma_ex311.htm EX-31.1 10474
3 CERTIFICATION drma_ex312.htm EX-31.2 10472
4 CERTIFICATION drma_ex321.htm EX-32.1 6596
  Complete submission text file 0001654954-23-006208.txt   2664263

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA drma-20230331.xsd EX-101.SCH 31225
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20230331_lab.xml EX-101.LAB 175372
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20230331_cal.xml EX-101.CAL 22611
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20230331_pre.xml EX-101.PRE 145469
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20230331_def.xml EX-101.DEF 88375
38 EXTRACTED XBRL INSTANCE DOCUMENT drma_10q_htm.xml XML 369208
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40739 | Film No.: 23910988
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences